# First National Corp: overview FXNC · Nasdaq · CIK 719402 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/fxnc.md) · [Financials](/companies/fxnc/financials.md) · [Filings](/companies/fxnc/filings.md) · [Insiders](/companies/fxnc/insiders.md) Latest reported revenue: [$3.4m](/filings/0001437749-26-027538.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 13, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001437749-26-027538). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [2.7](/filings/0001437749-25-035092.md) | [6.9 d](/filings/0001437749-26-009748.md) | [3.3](/filings/0001437749-26-016708.md) | [3.4](/filings/0001437749-26-027538.md) | [4.1](/filings/0001437749-25-035092.md) | [3.5 d](/filings/0001437749-26-009748.md) | [3.3](/filings/0001437749-26-016708.md) | [3.4](/filings/0001437749-26-027538.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [84.7%](/filings/0001437749-25-035092.md) | [(13.6%) d](/filings/0001437749-26-009748.md) | [48.8%](/filings/0001437749-26-016708.md) | [147.3%](/filings/0001437749-26-027538.md) | [135.1%](/filings/0001437749-25-035092.md) | [158.2% d](/filings/0001437749-26-009748.md) | [148.8%](/filings/0001437749-26-016708.md) | [168.0%](/filings/0001437749-26-027538.md) | | Diluted EPS | $ per share | [0.36](/filings/0001437749-25-035092.md) | not reported | [0.18](/filings/0001437749-26-016708.md) | [0.56](/filings/0001437749-26-027538.md) | [0.62](/filings/0001437749-25-035092.md) | not reported | [0.54](/filings/0001437749-26-016708.md) | [0.63](/filings/0001437749-26-027538.md) | | Free cash flow | $m | [4.9 d](/filings/0001437749-25-035092.md) | [(37.8) d](/filings/0001437749-26-009748.md) | [3.0](/filings/0001437749-26-016708.md) | [4.1 d](/filings/0001437749-26-027538.md) | [6.8 d](/filings/0001437749-25-035092.md) | [6.9 d](/filings/0001437749-26-009748.md) | [5.9](/filings/0001437749-26-016708.md) | [6.5 d](/filings/0001437749-26-027538.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [9.0](/filings/0001437749-23-008571.md) | [10.1](/filings/0001437749-24-010057.md) | [10.2](/filings/0001437749-25-010228.md) | [14.2](/filings/0001437749-26-009748.md) | [14.3](/filings/0001437749-26-009748.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [114.9%](/filings/0001437749-23-008571.md) | [166.8%](/filings/0001437749-24-010057.md) | [94.0%](/filings/0001437749-25-010228.md) | [49.1%](/filings/0001437749-26-009748.md) | [123.9%](/filings/0001437749-26-009748.md) | | Diluted EPS | $ per share | [1.86](/filings/0001437749-23-008571.md) | [2.68](/filings/0001437749-24-010057.md) | [1.53](/filings/0001437749-25-010228.md) | [1.00](/filings/0001437749-26-009748.md) | [1.96](/filings/0001437749-26-009748.md) | | Free cash flow | $m | [7.0](/filings/0001437749-23-008571.md) | [25.6](/filings/0001437749-24-010057.md) | [14.5](/filings/0001437749-25-010228.md) | [(25.5)](/filings/0001437749-26-009748.md) | [20.9](/filings/0001437749-26-009748.md) | - Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fxnc/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $16.5m | 549,166 | | Added +149,254 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $10.3m | 343,910 | | Added +17,453 | | [Petiole USA ltd](/funds/1600202.md) | 2026-06-30 | $9.2m | 305,340 | | Reduced −2,600 | | [Siena Capital Partners GP, LLC](/funds/1694886.md) | 2026-06-30 | $6.3m | 208,687 | | Reduced −67,356 | | [Cutler Capital Management, LLC](/funds/1353098.md) | 2026-06-30 | $6.1m | 203,809 | | Reduced −300 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.9m | 196,713 | | Added +17,093 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $4.4m | 146,258 | | Added +29,018 | | [De Lisle Partners LLP](/funds/2011184.md) | 2026-06-30 | $4.2m | 138,113 | | Unchanged | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $3.5m | 115,497 | | Added +85,227 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $3.3m | 110,354 | | Added +97,094 | ## Recent filings [All 992 filings](/companies/fxnc/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-23 | 08:32 ET | [8-K](/filings/0001437749-26-033337.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-033337 | | 2026-08-13 | 11:53 ET | [10-Q](/filings/0001437749-26-027538.md) | Quarterly report, period 2026-06-30 | 0001437749-26-027538 | | 2026-08-13 | 10:05 ET | [8-K](/filings/0001437749-26-027512.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-027512 | | 2026-07-29 | 09:19 ET | [8-K](/filings/0001437749-26-024769.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-024769 | | 2026-05-14 | 10:00 ET | [8-K](/filings/0001437749-26-016908.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-016908 | | 2026-05-13 | 16:01 ET | [10-Q](/filings/0001437749-26-016708.md) | Quarterly report, period 2026-03-31 | 0001437749-26-016708 | | 2026-05-13 | 10:01 ET | [8-K](/filings/0001437749-26-016572.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-016572 | | 2026-04-30 | 13:02 ET | [8-K](/filings/0001437749-26-014094.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-014094 | | 2026-04-02 | 12:10 ET | [DEF 14A](/filings/0001437749-26-011018.md) | Proxy statement, period 2026-05-13 | 0001437749-26-011018 | | 2026-03-25 | 14:14 ET | [10-K](/filings/0001437749-26-009748.md) | Annual report, period 2025-12-31 | 0001437749-26-009748 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-009748.md), filed Mar 25, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, locked when the 8-K was accepted. It is scored when the 10-Q or 10-K is ingested. [See the target](/leagues/2026q3/targets/978cc7df-2231-48e3-908b-907ca3156314) ## About the filer - CIK: 719402 - Tickers: FXNC - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: VA - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.